{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Fasting Requirements Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.3.1",
        "sectionTitle": "Fasting Requirements",
        "description": "Reference to fasting requirements for Visits 1-12"
      },
      {
        "id": "ref_2",
        "name": "Informed Consent Details Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.1.3",
        "sectionTitle": "Informed Consent Details",
        "description": "Appendix reference for additional informed consent details"
      },
      {
        "id": "ref_3",
        "name": "Adverse Events Definition Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.3",
        "sectionTitle": "Adverse Events",
        "description": "Appendix reference for AE definitions"
      },
      {
        "id": "ref_4",
        "name": "ECG Procedures Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.2.1",
        "sectionTitle": "ECG Procedures",
        "description": "Reference to ECG collection procedures"
      },
      {
        "id": "ref_5",
        "name": "Postmenopausal Status Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.4",
        "sectionTitle": "Reproductive Status",
        "description": "Appendix reference for confirming postmenopausal status"
      },
      {
        "id": "ref_6",
        "name": "HCV Testing Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.2.5",
        "sectionTitle": "HCV Testing",
        "description": "Reference to HCV RNA testing requirements"
      },
      {
        "id": "ref_7",
        "name": "HBV Testing Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.2.4",
        "sectionTitle": "HBV Testing",
        "description": "Reference to HBV DNA testing requirements"
      },
      {
        "id": "ref_8",
        "name": "Genetics Sample Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "10.5",
        "sectionTitle": "Genetics",
        "description": "Appendix reference for optional genetics sample collection"
      },
      {
        "id": "ref_9",
        "name": "Section 1.3 Self-Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.3",
        "sectionTitle": "Schedule of Activities",
        "description": "Self-reference for prescreening visit tolerance details"
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "Participants are required to fast before Visits 1-12. See Section 5.3.1. If a participant arrives not fasted, schedule the laboratory draw for another date.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 2
      },
      {
        "id": "annot_2",
        "text": "The ICF must be signed before any protocol-specific tests or procedures are performed.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 2
      },
      {
        "id": "annot_3",
        "text": "Inclusion and exclusion criteria should be confirmed prior to drug assignment and administration of first dose of study intervention.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 2
      },
      {
        "id": "annot_4",
        "text": "High risk for cardiovascular events will be defined as CAD, stroke, or peripheral artery disease, or ASCVD risk equivalents (familial hypercholesterolemia or type 2 diabetes)",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 2
      },
      {
        "id": "annot_5",
        "text": "Includes year of birth, sex, ethnicity (where permissible), and race.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Demographics",
        "pageNumber": 2
      },
      {
        "id": "annot_6",
        "text": "All conditions ongoing and relevant past surgical and medical history should be collected.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Medical History",
        "pageNumber": 2
      },
      {
        "id": "annot_7",
        "text": "Any events that occur after signing the informed consent are considered AEs as defined (Appendix 10.3). Additional data are collected for certain AEs.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - AEs",
        "pageNumber": 3
      },
      {
        "id": "annot_8",
        "text": "Participant should remove shoes.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Height/Weight",
        "pageNumber": 3
      },
      {
        "id": "annot_9",
        "text": "Includes pulse rate and blood pressure measured after participant has been sitting at least 5 minutes and before ECG tracing and collection of blood samples for laboratory testing.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Vital Signs",
        "pageNumber": 4
      },
      {
        "id": "annot_10",
        "text": "The physical examination is performed (excludes pelvic, rectal, and breast examinations unless clinically indicated).",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Physical Examination",
        "pageNumber": 4
      },
      {
        "id": "annot_11",
        "text": "Symptom-directed physical assessment will be conducted at the discretion of the PI or qualified personnel, per local regulations, as indicated based on participant status and standard of care.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Physical Assessment",
        "pageNumber": 4
      },
      {
        "id": "annot_12",
        "text": "Collect single, local ECG prior to collection of blood samples for laboratory testing, including PK samples. Participants should be supine for approximately 5 to 10 minutes before ECG collections and remain supine but awake during the ECG collection. ECGs may be repeated at the PI's discretion at any visit.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - 12-Lead ECG",
        "pageNumber": 4
      },
      {
        "id": "annot_13",
        "text": "Females only.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Serum Pregnancy",
        "pageNumber": 5
      },
      {
        "id": "annot_14",
        "text": "Optional; performed as needed to confirm postmenopausal status.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - FSH",
        "pageNumber": 5
      },
      {
        "id": "annot_15",
        "text": "If HCV antibody test is positive, it must be followed by an HCV RNA test.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - HCV Screening",
        "pageNumber": 6
      },
      {
        "id": "annot_16",
        "text": "If HBsAg is negative and HBcAb is positive, further testing with HBV DNA is required. If the screening HBV DNA is negative, the participant is not excluded.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - HBV Screening",
        "pageNumber": 6
      },
      {
        "id": "annot_17",
        "text": "Calculated using CKD-EPI method.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - eGFR",
        "pageNumber": 6
      },
      {
        "id": "annot_18",
        "text": "Visit 2: Collect 2 samples. 0.5 hours postdose, 4-9 hours postdose (minimum 2 hours). Visit 7: Collect 1 sample. 24-36 hours postdose, will require participant to return 1 day after Visit 7.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Postdose PK Sample",
        "pageNumber": 6
      },
      {
        "id": "annot_19",
        "text": "Visit 2 and 7 will be collected predose.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Immunogenicity",
        "pageNumber": 6
      },
      {
        "id": "annot_20",
        "text": "Collect a time-matched PK sample for all scheduled and unscheduled immunogenicity samples. Visit 7 will be collected predose.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - PK Sample for Immunogenicity",
        "pageNumber": 6
      },
      {
        "id": "annot_21",
        "text": "On dosing days, collect samples before dosing",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Stored Samples",
        "pageNumber": 7
      },
      {
        "id": "annot_22",
        "text": "Sample can be obtained at or after the specified visit.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Optional Genetics Sample",
        "pageNumber": 7
      },
      {
        "id": "annot_23",
        "text": "Unscheduled visits are not required to be registered in IWRS.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Register Visit with IWRS",
        "pageNumber": 7
      },
      {
        "id": "annot_24",
        "text": "P indicates predose collection",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 6
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "Not specified",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2022-07-19",
        "description": "Protocol J3L-MC-EZEB approved on 19 Jul 2022 GMT",
        "amendmentNumber": "Not specified"
      }
    ],
    "summary": {
      "referenceCount": 9,
      "annotationCount": 24,
      "versionCount": 1
    }
  }
}